Table Graph
      published meta-analysis   sensitivity analysis   studies

favipiravir in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death or transfer to ICUdetailed resultsjRCTs041190120, 2020 (REV) 0.98 [0.02; 50.37] 0.98[0.02; 50.37]jRCTs041190120, 2020 (REV)10%89NAnot evaluable deathsdetailed resultsSolaymani-Dodaran, 2021 1.22 [0.66; 2.26] 1.22[0.66; 2.26]Solaymani-Dodaran, 202110%373NAnot evaluable clinical improvement (time to event analysis only)detailed resultsSolaymani-Dodaran, 2021 0.94 [0.75; 1.17] 0.94[0.75; 1.17]Solaymani-Dodaran, 202110%380NAnot evaluable mechanical ventilationdetailed resultsSolaymani-Dodaran, 2021 1.62 [0.85; 3.08] 1.62[0.85; 3.08]Solaymani-Dodaran, 202110%373NAnot evaluable viral clearance detailed resultsjRCTs041190120, 2020 (REV) 0.71 [0.38; 1.31] 0.71[0.38; 1.31]jRCTs041190120, 2020 (REV)10%89NAnot evaluable viral clearance (time to event analysis only)detailed resultsjRCTs041190120, 2020 (REV) 0.71 [0.38; 1.31] 0.71[0.38; 1.31]jRCTs041190120, 2020 (REV)10%89NAnot evaluable ICU admissiondetailed resultsSolaymani-Dodaran, 2021 1.23 [0.70; 2.18] 1.23[0.70; 2.18]Solaymani-Dodaran, 202110%373NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-06-02 05:17 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 513 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons